[Relapse in acute lymphoblastic leukemia of childhood--treatment and results (author's transl)].
Twelve children with their first relapse of acute lymphoblastic leukemia who had the same initial therapy were treated on an out-patient basis. After 28 days all entered second remission. Medium remission duration was 11 months. At the end of the study seven patients were in continuous complete remission. Of the twelve children seven suffered bone marrow, two meningeal, two testicular relapses and one a combined bone marrow and meningeal relapse. Side effects were compatible with an out-patient treatment.
D000553:Ambulatory Care; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D001853:Bone Marrow; D001932:Brain Neoplasms / Q000556:secondary; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D008297:Male; D008577:Meningeal Neoplasms / Q000556:secondary; D012008:Recurrence; D013120:Spinal Cord Neoplasms / Q000556:secondary; D013736:Testicular Neoplasms / Q000556:secondary
D000970:Antineoplastic Agents
Rezidive bei akuter lymphatischer Leukämie im Kindesalter--Therapie und Ergobnisse.